VÄSTRA FRÖLUNDA, Sweden--(BUSINESS WIRE)--Regulatory News:
Artimplant AB (STO:ARTIB): v * Net revenue amounted to SEK 5.4 million (4.8).* * The net loss totaled SEK 3.9 million (4.7). * Earnings per stock unit amounted to SEK -0.03 (-0.08). * Artimplant’s own sales as a proportion of total sales continued to increase and were equivalent to 73% (51) of product sales. • The launch of complementary Artelon® Tissue Reinforcement products has commenced in the USA. * A new product for the treatment of osteoarthritis in the thumb base joint has been cleared for sale in Europe. * A new CFO – Kjell Thörnbring has been recruited and he has taken up his position.
